nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—Clobetasol propionate—psoriasis	0.0723	0.356	CrCtD
Prednisone—Corticosteroid Hormone Receptor Agonists—Fluocinonide—psoriasis	0.0622	0.22	CiPCiCtD
Prednisone—Corticosteroid Hormone Receptor Agonists—Fluocinolone Acetonide—psoriasis	0.0622	0.22	CiPCiCtD
Prednisone—psoriatic arthritis—psoriasis	0.0361	0.191	CtDrD
Prednisone—Corticosteroid Hormone Receptor Agonists—Hydrocortisone—psoriasis	0.0357	0.126	CiPCiCtD
Prednisone—systemic scleroderma—psoriasis	0.0348	0.185	CtDrD
Prednisone—atopic dermatitis—psoriasis	0.033	0.175	CtDrD
Prednisone—Corticosteroid Hormone Receptor Agonists—Dexamethasone—psoriasis	0.0314	0.111	CiPCiCtD
Prednisone—Corticosteroid Hormone Receptor Agonists—Betamethasone—psoriasis	0.0314	0.111	CiPCiCtD
Prednisone—Corticosteroid Hormone Receptor Agonists—Triamcinolone—psoriasis	0.0304	0.107	CiPCiCtD
Prednisone—ankylosing spondylitis—psoriasis	0.0297	0.157	CtDrD
Prednisone—Corticosteroid Hormone Receptor Agonists—Prednisolone—psoriasis	0.0294	0.104	CiPCiCtD
Prednisone—Hydrocortisone—psoriasis	0.0284	0.14	CrCtD
Prednisone—systemic lupus erythematosus—psoriasis	0.0284	0.15	CtDrD
Prednisone—rheumatoid arthritis—psoriasis	0.0268	0.142	CtDrD
Prednisone—Betamethasone—psoriasis	0.0264	0.13	CrCtD
Prednisone—Dexamethasone—psoriasis	0.0264	0.13	CrCtD
Prednisone—Triamcinolone—psoriasis	0.0258	0.127	CrCtD
Prednisone—Prednisolone—psoriasis	0.0239	0.118	CrCtD
Prednisone—NR3C1—Clobetasol propionate—psoriasis	0.0174	0.146	CbGbCtD
Prednisone—NR3C1—Beclomethasone—psoriasis	0.0132	0.111	CbGbCtD
Prednisone—NR3C1—Fluocinolone Acetonide—psoriasis	0.0132	0.111	CbGbCtD
Prednisone—NR3C1—Fluocinonide—psoriasis	0.0132	0.111	CbGbCtD
Prednisone—NR3C1—Triamcinolone—psoriasis	0.00524	0.0441	CbGbCtD
Prednisone—ALB—Acitretin—psoriasis	0.00498	0.0419	CbGbCtD
Prednisone—NR3C1—Betamethasone—psoriasis	0.0045	0.0378	CbGbCtD
Prednisone—NR3C1—Prednisolone—psoriasis	0.00444	0.0373	CbGbCtD
Prednisone—NR3C1—Hydrocortisone—psoriasis	0.0042	0.0354	CbGbCtD
Prednisone—SLCO1A2—Prednisolone—psoriasis	0.00382	0.0321	CbGbCtD
Prednisone—SLCO1A2—Hydrocortisone—psoriasis	0.00362	0.0305	CbGbCtD
Prednisone—SLCO1A2—Cyclosporine—psoriasis	0.00342	0.0288	CbGbCtD
Prednisone—NR3C1—Dexamethasone—psoriasis	0.00261	0.022	CbGbCtD
Prednisone—ALB—Mycophenolate mofetil—psoriasis	0.00233	0.0196	CbGbCtD
Prednisone—SLCO1A2—Dexamethasone—psoriasis	0.00225	0.0189	CbGbCtD
Prednisone—Ciclesonide—Clobetasol propionate—psoriasis	0.00205	0.0131	CrCrCtD
Prednisone—SLCO1A2—Methotrexate—psoriasis	0.00181	0.0152	CbGbCtD
Prednisone—CYP2C19—Cholecalciferol—psoriasis	0.00174	0.0147	CbGbCtD
Prednisone—Ciclesonide—Fluocinonide—psoriasis	0.00164	0.0105	CrCrCtD
Prednisone—Ciclesonide—Beclomethasone—psoriasis	0.00164	0.0105	CrCrCtD
Prednisone—CYP3A4—Calcitriol—psoriasis	0.00164	0.0138	CbGbCtD
Prednisone—Prednicarbate—Clobetasol propionate—psoriasis	0.00161	0.0103	CrCrCtD
Prednisone—Alclometasone—Clobetasol propionate—psoriasis	0.00152	0.00973	CrCrCtD
Prednisone—Amcinonide—Clobetasol propionate—psoriasis	0.00148	0.00947	CrCrCtD
Prednisone—Budesonide—Clobetasol propionate—psoriasis	0.00148	0.00947	CrCrCtD
Prednisone—Diflorasone—Clobetasol propionate—psoriasis	0.00145	0.00923	CrCrCtD
Prednisone—Fludrocortisone—Clobetasol propionate—psoriasis	0.00145	0.00923	CrCrCtD
Prednisone—Desonide—Clobetasol propionate—psoriasis	0.00145	0.00923	CrCrCtD
Prednisone—Paramethasone—Clobetasol propionate—psoriasis	0.00141	0.00899	CrCrCtD
Prednisone—Hydrocortamate—Beclomethasone—psoriasis	0.00137	0.00878	CrCrCtD
Prednisone—Desoximetasone—Clobetasol propionate—psoriasis	0.00137	0.00878	CrCrCtD
Prednisone—Fluprednidene Acetate—Clobetasol propionate—psoriasis	0.00134	0.00857	CrCrCtD
Prednisone—Loteprednol—Clobetasol propionate—psoriasis	0.00134	0.00857	CrCrCtD
Prednisone—Fluorometholone—Clobetasol propionate—psoriasis	0.00134	0.00857	CrCrCtD
Prednisone—Triamcinolone—Clobetasol propionate—psoriasis	0.00134	0.00857	CrCrCtD
Prednisone—Mometasone—Clobetasol propionate—psoriasis	0.00134	0.00857	CrCrCtD
Prednisone—Betamethasone—Clobetasol propionate—psoriasis	0.00131	0.00837	CrCrCtD
Prednisone—Dexamethasone—Clobetasol propionate—psoriasis	0.00131	0.00837	CrCrCtD
Prednisone—Rimexolone—Clobetasol propionate—psoriasis	0.00131	0.00837	CrCrCtD
Prednisone—Prednicarbate—Beclomethasone—psoriasis	0.00129	0.00825	CrCrCtD
Prednisone—CYP3A4—Methoxsalen—psoriasis	0.00127	0.0107	CbGbCtD
Prednisone—Fluocortolone—Fluocinonide—psoriasis	0.00126	0.00802	CrCrCtD
Prednisone—Methylprednisolone—Clobetasol propionate—psoriasis	0.00125	0.00801	CrCrCtD
Prednisone—Prednisolone—Clobetasol propionate—psoriasis	0.00123	0.00784	CrCrCtD
Prednisone—Alclometasone—Beclomethasone—psoriasis	0.00122	0.00779	CrCrCtD
Prednisone—Fluocortolone—Fluocinolone Acetonide—psoriasis	0.00122	0.00779	CrCrCtD
Prednisone—ABCB1—Mycophenolate mofetil—psoriasis	0.00122	0.0103	CbGbCtD
Prednisone—Amcinonide—Fluocinonide—psoriasis	0.00119	0.00759	CrCrCtD
Prednisone—Budesonide—Fluocinonide—psoriasis	0.00119	0.00759	CrCrCtD
Prednisone—Amcinonide—Beclomethasone—psoriasis	0.00119	0.00759	CrCrCtD
Prednisone—Budesonide—Beclomethasone—psoriasis	0.00119	0.00759	CrCrCtD
Prednisone—Alclometasone—Fluocinolone Acetonide—psoriasis	0.00119	0.00757	CrCrCtD
Prednisone—Diflorasone—Fluocinonide—psoriasis	0.00116	0.00739	CrCrCtD
Prednisone—Flunisolide—Fluocinonide—psoriasis	0.00116	0.00739	CrCrCtD
Prednisone—Diflorasone—Beclomethasone—psoriasis	0.00116	0.00739	CrCrCtD
Prednisone—Clobetasol propionate—Fluocinonide—psoriasis	0.00116	0.00739	CrCrCtD
Prednisone—Desonide—Fluocinonide—psoriasis	0.00116	0.00739	CrCrCtD
Prednisone—Clobetasol propionate—Beclomethasone—psoriasis	0.00116	0.00739	CrCrCtD
Prednisone—Desonide—Beclomethasone—psoriasis	0.00116	0.00739	CrCrCtD
Prednisone—Amcinonide—Fluocinolone Acetonide—psoriasis	0.00115	0.00737	CrCrCtD
Prednisone—Budesonide—Fluocinolone Acetonide—psoriasis	0.00115	0.00737	CrCrCtD
Prednisone—CYP2C19—Cyclosporine—psoriasis	0.00115	0.00964	CbGbCtD
Prednisone—Paramethasone—Fluocinonide—psoriasis	0.00113	0.0072	CrCrCtD
Prednisone—Diflorasone—Fluocinolone Acetonide—psoriasis	0.00112	0.00718	CrCrCtD
Prednisone—Clobetasol propionate—Fluocinolone Acetonide—psoriasis	0.00112	0.00718	CrCrCtD
Prednisone—Desonide—Fluocinolone Acetonide—psoriasis	0.00112	0.00718	CrCrCtD
Prednisone—Fludrocortisone—Fluocinolone Acetonide—psoriasis	0.00112	0.00718	CrCrCtD
Prednisone—Flunisolide—Fluocinolone Acetonide—psoriasis	0.00112	0.00718	CrCrCtD
Prednisone—Desoximetasone—Fluocinonide—psoriasis	0.0011	0.00703	CrCrCtD
Prednisone—Desoximetasone—Beclomethasone—psoriasis	0.0011	0.00703	CrCrCtD
Prednisone—Paramethasone—Fluocinolone Acetonide—psoriasis	0.0011	0.007	CrCrCtD
Prednisone—Loteprednol—Beclomethasone—psoriasis	0.00108	0.00686	CrCrCtD
Prednisone—Fluprednidene Acetate—Beclomethasone—psoriasis	0.00108	0.00686	CrCrCtD
Prednisone—Fluprednidene Acetate—Fluocinonide—psoriasis	0.00108	0.00686	CrCrCtD
Prednisone—Mometasone—Beclomethasone—psoriasis	0.00108	0.00686	CrCrCtD
Prednisone—Triamcinolone—Beclomethasone—psoriasis	0.00108	0.00686	CrCrCtD
Prednisone—Mometasone—Fluocinonide—psoriasis	0.00108	0.00686	CrCrCtD
Prednisone—Triamcinolone—Fluocinonide—psoriasis	0.00108	0.00686	CrCrCtD
Prednisone—Fluorometholone—Beclomethasone—psoriasis	0.00108	0.00686	CrCrCtD
Prednisone—Fluorometholone—Fluocinonide—psoriasis	0.00108	0.00686	CrCrCtD
Prednisone—Desoximetasone—Fluocinolone Acetonide—psoriasis	0.00107	0.00683	CrCrCtD
Prednisone—Betamethasone—Beclomethasone—psoriasis	0.00105	0.00671	CrCrCtD
Prednisone—Rimexolone—Fluocinonide—psoriasis	0.00105	0.00671	CrCrCtD
Prednisone—Dexamethasone—Beclomethasone—psoriasis	0.00105	0.00671	CrCrCtD
Prednisone—Betamethasone—Fluocinonide—psoriasis	0.00105	0.00671	CrCrCtD
Prednisone—Dexamethasone—Fluocinonide—psoriasis	0.00105	0.00671	CrCrCtD
Prednisone—Rimexolone—Beclomethasone—psoriasis	0.00105	0.00671	CrCrCtD
Prednisone—ABCB1—Betamethasone—psoriasis	0.00105	0.0088	CbGbCtD
Prednisone—Mometasone—Fluocinolone Acetonide—psoriasis	0.00104	0.00667	CrCrCtD
Prednisone—Triamcinolone—Fluocinolone Acetonide—psoriasis	0.00104	0.00667	CrCrCtD
Prednisone—Fluorometholone—Fluocinolone Acetonide—psoriasis	0.00104	0.00667	CrCrCtD
Prednisone—Fluprednidene Acetate—Fluocinolone Acetonide—psoriasis	0.00104	0.00667	CrCrCtD
Prednisone—ABCB1—Prednisolone—psoriasis	0.00103	0.00869	CbGbCtD
Prednisone—Betamethasone—Fluocinolone Acetonide—psoriasis	0.00102	0.00652	CrCrCtD
Prednisone—Rimexolone—Fluocinolone Acetonide—psoriasis	0.00102	0.00652	CrCrCtD
Prednisone—Dexamethasone—Fluocinolone Acetonide—psoriasis	0.00102	0.00652	CrCrCtD
Prednisone—Exemestane—Prednisolone—psoriasis	0.00102	0.00651	CrCrCtD
Prednisone—Methylprednisolone—Fluocinonide—psoriasis	0.001	0.00641	CrCrCtD
Prednisone—Prednisolone—Beclomethasone—psoriasis	0.000984	0.00628	CrCrCtD
Prednisone—ABCB1—Hydrocortisone—psoriasis	0.000979	0.00823	CbGbCtD
Prednisone—Methylprednisolone—Fluocinolone Acetonide—psoriasis	0.000976	0.00623	CrCrCtD
Prednisone—Prednisolone—Fluocinolone Acetonide—psoriasis	0.000956	0.0061	CrCrCtD
Prednisone—ALB—Methotrexate—psoriasis	0.000936	0.00787	CbGbCtD
Prednisone—ABCB1—Cyclosporine—psoriasis	0.000925	0.00778	CbGbCtD
Prednisone—Potassium Canrenoate—Hydrocortisone—psoriasis	0.000919	0.00586	CrCrCtD
Prednisone—CYP3A4—Cholecalciferol—psoriasis	0.000843	0.00709	CbGbCtD
Prednisone—Ciclesonide—Hydrocortisone—psoriasis	0.000807	0.00515	CrCrCtD
Prednisone—Danazol—Hydrocortisone—psoriasis	0.000776	0.00495	CrCrCtD
Prednisone—Potassium Canrenoate—Prednisolone—psoriasis	0.000772	0.00493	CrCrCtD
Prednisone—CYP2C19—Dexamethasone—psoriasis	0.000755	0.00635	CbGbCtD
Prednisone—CYP3A4—Triamcinolone—psoriasis	0.000731	0.00615	CbGbCtD
Prednisone—CYP3A4—Mycophenolate mofetil—psoriasis	0.000731	0.00615	CbGbCtD
Prednisone—Ciclesonide—Prednisolone—psoriasis	0.000678	0.00433	CrCrCtD
Prednisone—Hydrocortamate—Hydrocortisone—psoriasis	0.000675	0.00431	CrCrCtD
Prednisone—Cortisone acetate—Hydrocortisone—psoriasis	0.000654	0.00417	CrCrCtD
Prednisone—Prednicarbate—Hydrocortisone—psoriasis	0.000634	0.00405	CrCrCtD
Prednisone—CYP3A4—Betamethasone—psoriasis	0.000627	0.00527	CbGbCtD
Prednisone—CYP3A4—Prednisolone—psoriasis	0.000619	0.0052	CbGbCtD
Prednisone—ABCB1—Dexamethasone—psoriasis	0.000609	0.00512	CbGbCtD
Prednisone—Alclometasone—Hydrocortisone—psoriasis	0.000599	0.00383	CrCrCtD
Prednisone—Prednicarbate—Dexamethasone—psoriasis	0.000589	0.00376	CrCrCtD
Prednisone—Prednicarbate—Betamethasone—psoriasis	0.000589	0.00376	CrCrCtD
Prednisone—Testolactone—Betamethasone—psoriasis	0.000589	0.00376	CrCrCtD
Prednisone—Testolactone—Dexamethasone—psoriasis	0.000589	0.00376	CrCrCtD
Prednisone—CYP3A4—Hydrocortisone—psoriasis	0.000587	0.00493	CbGbCtD
Prednisone—Budesonide—Hydrocortisone—psoriasis	0.000583	0.00372	CrCrCtD
Prednisone—Prednicarbate—Triamcinolone—psoriasis	0.000576	0.00368	CrCrCtD
Prednisone—Testolactone—Triamcinolone—psoriasis	0.000576	0.00368	CrCrCtD
Prednisone—Fluocortolone—Betamethasone—psoriasis	0.000572	0.00365	CrCrCtD
Prednisone—Fluocortolone—Dexamethasone—psoriasis	0.000572	0.00365	CrCrCtD
Prednisone—Desonide—Hydrocortisone—psoriasis	0.000568	0.00363	CrCrCtD
Prednisone—Flunisolide—Hydrocortisone—psoriasis	0.000568	0.00363	CrCrCtD
Prednisone—Fludrocortisone—Hydrocortisone—psoriasis	0.000568	0.00363	CrCrCtD
Prednisone—Hydrocortamate—Prednisolone—psoriasis	0.000567	0.00362	CrCrCtD
Prednisone—Fluocortolone—Triamcinolone—psoriasis	0.000559	0.00357	CrCrCtD
Prednisone—Alclometasone—Betamethasone—psoriasis	0.000557	0.00355	CrCrCtD
Prednisone—Alclometasone—Dexamethasone—psoriasis	0.000557	0.00355	CrCrCtD
Prednisone—CYP3A4—Cyclosporine—psoriasis	0.000554	0.00466	CbGbCtD
Prednisone—Paramethasone—Hydrocortisone—psoriasis	0.000554	0.00354	CrCrCtD
Prednisone—Methyltestosterone—Hydrocortisone—psoriasis	0.000554	0.00354	CrCrCtD
Prednisone—Cortisone acetate—Prednisolone—psoriasis	0.00055	0.00351	CrCrCtD
Prednisone—Alclometasone—Triamcinolone—psoriasis	0.000544	0.00347	CrCrCtD
Prednisone—Amcinonide—Betamethasone—psoriasis	0.000542	0.00346	CrCrCtD
Prednisone—Amcinonide—Dexamethasone—psoriasis	0.000542	0.00346	CrCrCtD
Prednisone—Budesonide—Betamethasone—psoriasis	0.000542	0.00346	CrCrCtD
Prednisone—Budesonide—Dexamethasone—psoriasis	0.000542	0.00346	CrCrCtD
Prednisone—Desoximetasone—Hydrocortisone—psoriasis	0.00054	0.00345	CrCrCtD
Prednisone—Prednicarbate—Prednisolone—psoriasis	0.000533	0.0034	CrCrCtD
Prednisone—Testolactone—Prednisolone—psoriasis	0.000533	0.0034	CrCrCtD
Prednisone—Amcinonide—Triamcinolone—psoriasis	0.000529	0.00338	CrCrCtD
Prednisone—Budesonide—Triamcinolone—psoriasis	0.000529	0.00338	CrCrCtD
Prednisone—Mometasone—Hydrocortisone—psoriasis	0.000528	0.00337	CrCrCtD
Prednisone—Fluprednidene Acetate—Hydrocortisone—psoriasis	0.000528	0.00337	CrCrCtD
Prednisone—Loteprednol—Hydrocortisone—psoriasis	0.000528	0.00337	CrCrCtD
Prednisone—Triamcinolone—Hydrocortisone—psoriasis	0.000528	0.00337	CrCrCtD
Prednisone—Fluorometholone—Hydrocortisone—psoriasis	0.000528	0.00337	CrCrCtD
Prednisone—Clobetasol propionate—Dexamethasone—psoriasis	0.000528	0.00337	CrCrCtD
Prednisone—Diflorasone—Betamethasone—psoriasis	0.000528	0.00337	CrCrCtD
Prednisone—Desonide—Dexamethasone—psoriasis	0.000528	0.00337	CrCrCtD
Prednisone—Desonide—Betamethasone—psoriasis	0.000528	0.00337	CrCrCtD
Prednisone—Clobetasol propionate—Betamethasone—psoriasis	0.000528	0.00337	CrCrCtD
Prednisone—Fludrocortisone—Betamethasone—psoriasis	0.000528	0.00337	CrCrCtD
Prednisone—Flunisolide—Betamethasone—psoriasis	0.000528	0.00337	CrCrCtD
Prednisone—Flunisolide—Dexamethasone—psoriasis	0.000528	0.00337	CrCrCtD
Prednisone—Fludrocortisone—Dexamethasone—psoriasis	0.000528	0.00337	CrCrCtD
Prednisone—Diflorasone—Dexamethasone—psoriasis	0.000528	0.00337	CrCrCtD
Prednisone—Fluocortolone—Prednisolone—psoriasis	0.000518	0.00331	CrCrCtD
Prednisone—Betamethasone—Hydrocortisone—psoriasis	0.000516	0.00329	CrCrCtD
Prednisone—Dexamethasone—Hydrocortisone—psoriasis	0.000516	0.00329	CrCrCtD
Prednisone—Rimexolone—Hydrocortisone—psoriasis	0.000516	0.00329	CrCrCtD
Prednisone—Diflorasone—Triamcinolone—psoriasis	0.000515	0.00329	CrCrCtD
Prednisone—Flunisolide—Triamcinolone—psoriasis	0.000515	0.00329	CrCrCtD
Prednisone—Clobetasol propionate—Triamcinolone—psoriasis	0.000515	0.00329	CrCrCtD
Prednisone—Desonide—Triamcinolone—psoriasis	0.000515	0.00329	CrCrCtD
Prednisone—Fludrocortisone—Triamcinolone—psoriasis	0.000515	0.00329	CrCrCtD
Prednisone—Paramethasone—Dexamethasone—psoriasis	0.000514	0.00328	CrCrCtD
Prednisone—Paramethasone—Betamethasone—psoriasis	0.000514	0.00328	CrCrCtD
Prednisone—Alclometasone—Prednisolone—psoriasis	0.000504	0.00322	CrCrCtD
Prednisone—Paramethasone—Triamcinolone—psoriasis	0.000503	0.00321	CrCrCtD
Prednisone—Desoximetasone—Betamethasone—psoriasis	0.000502	0.0032	CrCrCtD
Prednisone—Desoximetasone—Dexamethasone—psoriasis	0.000502	0.0032	CrCrCtD
Prednisone—Methylprednisolone—Hydrocortisone—psoriasis	0.000493	0.00315	CrCrCtD
Prednisone—Desoximetasone—Triamcinolone—psoriasis	0.00049	0.00313	CrCrCtD
Prednisone—Amcinonide—Prednisolone—psoriasis	0.00049	0.00313	CrCrCtD
Prednisone—Budesonide—Prednisolone—psoriasis	0.00049	0.00313	CrCrCtD
Prednisone—Loteprednol—Dexamethasone—psoriasis	0.00049	0.00313	CrCrCtD
Prednisone—Mometasone—Dexamethasone—psoriasis	0.00049	0.00313	CrCrCtD
Prednisone—Mometasone—Betamethasone—psoriasis	0.00049	0.00313	CrCrCtD
Prednisone—Triamcinolone—Dexamethasone—psoriasis	0.00049	0.00313	CrCrCtD
Prednisone—Fluorometholone—Betamethasone—psoriasis	0.00049	0.00313	CrCrCtD
Prednisone—Fluorometholone—Dexamethasone—psoriasis	0.00049	0.00313	CrCrCtD
Prednisone—Loteprednol—Betamethasone—psoriasis	0.00049	0.00313	CrCrCtD
Prednisone—Fluprednidene Acetate—Betamethasone—psoriasis	0.00049	0.00313	CrCrCtD
Prednisone—Fluprednidene Acetate—Dexamethasone—psoriasis	0.00049	0.00313	CrCrCtD
Prednisone—Triamcinolone—Betamethasone—psoriasis	0.00049	0.00313	CrCrCtD
Prednisone—ABCB1—Methotrexate—psoriasis	0.000489	0.00412	CbGbCtD
Prednisone—Prednisolone—Hydrocortisone—psoriasis	0.000483	0.00308	CrCrCtD
Prednisone—Betamethasone—Dexamethasone—psoriasis	0.000479	0.00306	CrCrCtD
Prednisone—Rimexolone—Dexamethasone—psoriasis	0.000479	0.00306	CrCrCtD
Prednisone—Rimexolone—Betamethasone—psoriasis	0.000479	0.00306	CrCrCtD
Prednisone—Dexamethasone—Betamethasone—psoriasis	0.000479	0.00306	CrCrCtD
Prednisone—Fluprednidene Acetate—Triamcinolone—psoriasis	0.000479	0.00306	CrCrCtD
Prednisone—Loteprednol—Triamcinolone—psoriasis	0.000479	0.00306	CrCrCtD
Prednisone—Fluorometholone—Triamcinolone—psoriasis	0.000479	0.00306	CrCrCtD
Prednisone—Mometasone—Triamcinolone—psoriasis	0.000479	0.00306	CrCrCtD
Prednisone—Clobetasol propionate—Prednisolone—psoriasis	0.000478	0.00305	CrCrCtD
Prednisone—Desonide—Prednisolone—psoriasis	0.000478	0.00305	CrCrCtD
Prednisone—Fludrocortisone—Prednisolone—psoriasis	0.000478	0.00305	CrCrCtD
Prednisone—Diflorasone—Prednisolone—psoriasis	0.000478	0.00305	CrCrCtD
Prednisone—Flunisolide—Prednisolone—psoriasis	0.000478	0.00305	CrCrCtD
Prednisone—Betamethasone—Triamcinolone—psoriasis	0.000468	0.00299	CrCrCtD
Prednisone—Dexamethasone—Triamcinolone—psoriasis	0.000468	0.00299	CrCrCtD
Prednisone—Rimexolone—Triamcinolone—psoriasis	0.000468	0.00299	CrCrCtD
Prednisone—Methyltestosterone—Prednisolone—psoriasis	0.000466	0.00297	CrCrCtD
Prednisone—Paramethasone—Prednisolone—psoriasis	0.000466	0.00297	CrCrCtD
Prednisone—Methylprednisolone—Betamethasone—psoriasis	0.000458	0.00292	CrCrCtD
Prednisone—Methylprednisolone—Dexamethasone—psoriasis	0.000458	0.00292	CrCrCtD
Prednisone—Desoximetasone—Prednisolone—psoriasis	0.000454	0.0029	CrCrCtD
Prednisone—Prednisolone—Dexamethasone—psoriasis	0.000448	0.00286	CrCrCtD
Prednisone—Prednisolone—Betamethasone—psoriasis	0.000448	0.00286	CrCrCtD
Prednisone—Methylprednisolone—Triamcinolone—psoriasis	0.000447	0.00286	CrCrCtD
Prednisone—Loteprednol—Prednisolone—psoriasis	0.000444	0.00283	CrCrCtD
Prednisone—Fluprednidene Acetate—Prednisolone—psoriasis	0.000444	0.00283	CrCrCtD
Prednisone—Fluorometholone—Prednisolone—psoriasis	0.000444	0.00283	CrCrCtD
Prednisone—Triamcinolone—Prednisolone—psoriasis	0.000444	0.00283	CrCrCtD
Prednisone—Mometasone—Prednisolone—psoriasis	0.000444	0.00283	CrCrCtD
Prednisone—Prednisolone—Triamcinolone—psoriasis	0.000438	0.0028	CrCrCtD
Prednisone—Betamethasone—Prednisolone—psoriasis	0.000433	0.00277	CrCrCtD
Prednisone—Dexamethasone—Prednisolone—psoriasis	0.000433	0.00277	CrCrCtD
Prednisone—Rimexolone—Prednisolone—psoriasis	0.000433	0.00277	CrCrCtD
Prednisone—Hydrocortisone—Dexamethasone—psoriasis	0.00043	0.00275	CrCrCtD
Prednisone—Hydrocortisone—Betamethasone—psoriasis	0.00043	0.00275	CrCrCtD
Prednisone—Hydrocortisone—Triamcinolone—psoriasis	0.00042	0.00268	CrCrCtD
Prednisone—Methylprednisolone—Prednisolone—psoriasis	0.000415	0.00265	CrCrCtD
Prednisone—Hydrocortisone—Prednisolone—psoriasis	0.000389	0.00249	CrCrCtD
Prednisone—CYP3A4—Dexamethasone—psoriasis	0.000365	0.00307	CbGbCtD
Prednisone—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	7.89e-05	0.0661	CbGpPWpGaD
Prednisone—CYP2C19—Xenobiotics—CYP2S1—psoriasis	4.89e-05	0.041	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—IL22—psoriasis	3.83e-05	0.0321	CbGpPWpGaD
Prednisone—CYP3A4—Xenobiotics—CYP2S1—psoriasis	2.94e-05	0.0246	CbGpPWpGaD
Prednisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CARM1—psoriasis	2.65e-05	0.0222	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—NDUFA5—psoriasis	2.2e-05	0.0185	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.05e-05	0.0172	CbGpPWpGaD
Prednisone—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	2.03e-05	0.017	CbGpPWpGaD
Prednisone—NR3C1—Regulation of Androgen receptor activity—REL—psoriasis	2.02e-05	0.0169	CbGpPWpGaD
Prednisone—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	2e-05	0.0168	CbGpPWpGaD
Prednisone—NR3C1—Regulation of Androgen receptor activity—CARM1—psoriasis	1.99e-05	0.0167	CbGpPWpGaD
Prednisone—NR3C1—Circadian Clock—CARM1—psoriasis	1.93e-05	0.0162	CbGpPWpGaD
Prednisone—NR3C1—Transcription factor regulation in adipogenesis—LEP—psoriasis	1.92e-05	0.0161	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—CYP2S1—psoriasis	1.87e-05	0.0157	CbGpPWpGaD
Prednisone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—psoriasis	1.67e-05	0.014	CbGpPWpGaD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	1.67e-05	0.014	CbGpPWpGaD
Prednisone—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	1.65e-05	0.0138	CbGpPWpGaD
Prednisone—ALB—HDL-mediated lipid transport—APOE—psoriasis	1.6e-05	0.0134	CbGpPWpGaD
Prednisone—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	1.58e-05	0.0133	CbGpPWpGaD
Prednisone—NR3C1—Nuclear Receptors—VDR—psoriasis	1.55e-05	0.013	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—IL13—psoriasis	1.3e-05	0.0109	CbGpPWpGaD
Prednisone—NR3C1—Nuclear Receptor transcription pathway—VDR—psoriasis	1.22e-05	0.0103	CbGpPWpGaD
Prednisone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	1.22e-05	0.0102	CbGpPWpGaD
Prednisone—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	1.2e-05	0.0101	CbGpPWpGaD
Prednisone—NR3C1—Nuclear Receptors—PPARG—psoriasis	1.08e-05	0.00906	CbGpPWpGaD
Prednisone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	9.9e-06	0.0083	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—RUNX3—psoriasis	9.86e-06	0.00827	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.81e-06	0.00822	CbGpPWpGaD
Prednisone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	9.76e-06	0.00818	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	9.4e-06	0.00788	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—IL10—psoriasis	9.25e-06	0.00775	CbGpPWpGaD
Prednisone—ALB—Lipoprotein metabolism—APOE—psoriasis	9.19e-06	0.0077	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—CARM1—psoriasis	9.14e-06	0.00766	CbGpPWpGaD
Prednisone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	9.1e-06	0.00763	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—IL4—psoriasis	9e-06	0.00754	CbGpPWpGaD
Prednisone—NR3C1—Transcription factor regulation in adipogenesis—TNF—psoriasis	8.89e-06	0.00745	CbGpPWpGaD
Prednisone—CYP2C19—Biological oxidations—CYP2S1—psoriasis	8.74e-06	0.00733	CbGpPWpGaD
Prednisone—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	8.62e-06	0.00723	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.54e-06	0.00716	CbGpPWpGaD
Prednisone—NR3C1—Nuclear Receptor transcription pathway—PPARG—psoriasis	8.54e-06	0.00716	CbGpPWpGaD
Prednisone—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	8.48e-06	0.0071	CbGpPWpGaD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	8.46e-06	0.00709	CbGpPWpGaD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	8.23e-06	0.0069	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—HLA-A—psoriasis	8.15e-06	0.00683	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—IL4—psoriasis	7.93e-06	0.00664	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—IL13—psoriasis	7.79e-06	0.00653	CbGpPWpGaD
Prednisone—ALB—Hemostasis—SERPINB8—psoriasis	7.5e-06	0.00628	CbGpPWpGaD
Prednisone—SLCO1A2—SLC-mediated transmembrane transport—CP—psoriasis	7.33e-06	0.00615	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—HLA-C—psoriasis	7.26e-06	0.00608	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—IL13—psoriasis	7.21e-06	0.00604	CbGpPWpGaD
Prednisone—NR3C1—Transcription factor regulation in adipogenesis—IL6—psoriasis	7.17e-06	0.00601	CbGpPWpGaD
Prednisone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	7.16e-06	0.006	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—IL17A—psoriasis	6.64e-06	0.00556	CbGpPWpGaD
Prednisone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.35e-06	0.00532	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—psoriasis	6.3e-06	0.00528	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—CAT—psoriasis	6.29e-06	0.00528	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—SOCS1—psoriasis	6.28e-06	0.00527	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—IL12B—psoriasis	6.17e-06	0.00517	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—CRP—psoriasis	6.14e-06	0.00515	CbGpPWpGaD
Prednisone—ALB—Lipid and lipoprotein metabolism—APOE—psoriasis	6.11e-06	0.00512	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—HLA-E—psoriasis	6.02e-06	0.00505	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—APOE—psoriasis	6.01e-06	0.00504	CbGpPWpGaD
Prednisone—NR3C1—Regulation of Androgen receptor activity—JUN—psoriasis	5.87e-06	0.00492	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—IL4—psoriasis	5.78e-06	0.00485	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—ICAM1—psoriasis	5.65e-06	0.00473	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—CAT—psoriasis	5.62e-06	0.00471	CbGpPWpGaD
Prednisone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	5.61e-06	0.0047	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—IFNG—psoriasis	5.44e-06	0.00456	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—TARS—psoriasis	5.42e-06	0.00454	CbGpPWpGaD
Prednisone—Neutropenia—Methotrexate—psoriasis	5.42e-06	0.000112	CcSEcCtD
Prednisone—Insomnia—Cyclosporine—psoriasis	5.39e-06	0.000111	CcSEcCtD
Prednisone—Loss of consciousness—Triamcinolone—psoriasis	5.37e-06	0.000111	CcSEcCtD
Prednisone—Paraesthesia—Cyclosporine—psoriasis	5.35e-06	0.00011	CcSEcCtD
Prednisone—Shock—Prednisolone—psoriasis	5.34e-06	0.00011	CcSEcCtD
Prednisone—Erectile dysfunction—Methotrexate—psoriasis	5.33e-06	0.00011	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	5.3e-06	0.000109	CcSEcCtD
Prednisone—Oedema—Hydrocortisone—psoriasis	5.3e-06	0.000109	CcSEcCtD
Prednisone—Anaphylactic shock—Hydrocortisone—psoriasis	5.3e-06	0.000109	CcSEcCtD
Prednisone—Convulsion—Triamcinolone—psoriasis	5.29e-06	0.000109	CcSEcCtD
Prednisone—Tachycardia—Prednisolone—psoriasis	5.29e-06	0.000109	CcSEcCtD
Prednisone—Asthenia—Mycophenolic acid—psoriasis	5.29e-06	0.000109	CcSEcCtD
Prednisone—Hypertension—Triamcinolone—psoriasis	5.28e-06	0.000109	CcSEcCtD
Prednisone—Infection—Hydrocortisone—psoriasis	5.26e-06	0.000108	CcSEcCtD
Prednisone—Insomnia—Mycophenolate mofetil—psoriasis	5.26e-06	0.000108	CcSEcCtD
Prednisone—CYP3A4—Biological oxidations—CYP2S1—psoriasis	5.26e-06	0.00441	CbGpPWpGaD
Prednisone—Dyspepsia—Cyclosporine—psoriasis	5.25e-06	0.000108	CcSEcCtD
Prednisone—Hyperhidrosis—Prednisolone—psoriasis	5.24e-06	0.000108	CcSEcCtD
Prednisone—Nausea—Hydroxyurea—psoriasis	5.22e-06	0.000108	CcSEcCtD
Prednisone—Paraesthesia—Mycophenolate mofetil—psoriasis	5.22e-06	0.000108	CcSEcCtD
Prednisone—Pruritus—Mycophenolic acid—psoriasis	5.21e-06	0.000107	CcSEcCtD
Prednisone—Shock—Hydrocortisone—psoriasis	5.21e-06	0.000107	CcSEcCtD
Prednisone—Myalgia—Triamcinolone—psoriasis	5.2e-06	0.000107	CcSEcCtD
Prednisone—Nervous system disorder—Hydrocortisone—psoriasis	5.19e-06	0.000107	CcSEcCtD
Prednisone—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	5.18e-06	0.00435	CbGpPWpGaD
Prednisone—Decreased appetite—Cyclosporine—psoriasis	5.18e-06	0.000107	CcSEcCtD
Prednisone—Tachycardia—Hydrocortisone—psoriasis	5.17e-06	0.000107	CcSEcCtD
Prednisone—Depression—Methotrexate—psoriasis	5.15e-06	0.000106	CcSEcCtD
Prednisone—Skin disorder—Hydrocortisone—psoriasis	5.14e-06	0.000106	CcSEcCtD
Prednisone—Ill-defined disorder—Betamethasone—psoriasis	5.14e-06	0.000106	CcSEcCtD
Prednisone—Ill-defined disorder—Dexamethasone—psoriasis	5.14e-06	0.000106	CcSEcCtD
Prednisone—Discomfort—Triamcinolone—psoriasis	5.14e-06	0.000106	CcSEcCtD
Prednisone—Fatigue—Cyclosporine—psoriasis	5.14e-06	0.000106	CcSEcCtD
Prednisone—Hyperhidrosis—Hydrocortisone—psoriasis	5.12e-06	0.000106	CcSEcCtD
Prednisone—Dyspepsia—Mycophenolate mofetil—psoriasis	5.12e-06	0.000105	CcSEcCtD
Prednisone—Constipation—Cyclosporine—psoriasis	5.1e-06	0.000105	CcSEcCtD
Prednisone—Angioedema—Dexamethasone—psoriasis	5.07e-06	0.000104	CcSEcCtD
Prednisone—Angioedema—Betamethasone—psoriasis	5.07e-06	0.000104	CcSEcCtD
Prednisone—NR3C1—AP-1 transcription factor network—CXCL8—psoriasis	5.06e-06	0.00424	CbGpPWpGaD
Prednisone—Decreased appetite—Mycophenolate mofetil—psoriasis	5.05e-06	0.000104	CcSEcCtD
Prednisone—Anorexia—Hydrocortisone—psoriasis	5.05e-06	0.000104	CcSEcCtD
Prednisone—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	5.04e-06	0.00423	CbGpPWpGaD
Prednisone—Diarrhoea—Mycophenolic acid—psoriasis	5.04e-06	0.000104	CcSEcCtD
Prednisone—ALB—Selenium Micronutrient Network—CAT—psoriasis	5e-06	0.00419	CbGpPWpGaD
Prednisone—Malaise—Dexamethasone—psoriasis	5e-06	0.000103	CcSEcCtD
Prednisone—Malaise—Betamethasone—psoriasis	5e-06	0.000103	CcSEcCtD
Prednisone—ALB—Folate Metabolism—CRP—psoriasis	5e-06	0.00419	CbGpPWpGaD
Prednisone—Oedema—Triamcinolone—psoriasis	4.99e-06	0.000103	CcSEcCtD
Prednisone—Anaphylactic shock—Triamcinolone—psoriasis	4.99e-06	0.000103	CcSEcCtD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	4.98e-06	0.00418	CbGpPWpGaD
Prednisone—Vertigo—Dexamethasone—psoriasis	4.98e-06	0.000103	CcSEcCtD
Prednisone—Vertigo—Betamethasone—psoriasis	4.98e-06	0.000103	CcSEcCtD
Prednisone—Syncope—Dexamethasone—psoriasis	4.97e-06	0.000102	CcSEcCtD
Prednisone—Syncope—Betamethasone—psoriasis	4.97e-06	0.000102	CcSEcCtD
Prednisone—Constipation—Mycophenolate mofetil—psoriasis	4.97e-06	0.000102	CcSEcCtD
Prednisone—Infection—Triamcinolone—psoriasis	4.95e-06	0.000102	CcSEcCtD
Prednisone—Feeling abnormal—Cyclosporine—psoriasis	4.91e-06	0.000101	CcSEcCtD
Prednisone—Shock—Triamcinolone—psoriasis	4.91e-06	0.000101	CcSEcCtD
Prednisone—Insomnia—Prednisolone—psoriasis	4.91e-06	0.000101	CcSEcCtD
Prednisone—Gastrointestinal pain—Cyclosporine—psoriasis	4.87e-06	0.0001	CcSEcCtD
Prednisone—Loss of consciousness—Dexamethasone—psoriasis	4.87e-06	0.0001	CcSEcCtD
Prednisone—Loss of consciousness—Betamethasone—psoriasis	4.87e-06	0.0001	CcSEcCtD
Prednisone—NR3C1—SIDS Susceptibility Pathways—IL10—psoriasis	4.87e-06	0.00408	CbGpPWpGaD
Prednisone—Dizziness—Mycophenolic acid—psoriasis	4.87e-06	0.0001	CcSEcCtD
Prednisone—Paraesthesia—Prednisolone—psoriasis	4.87e-06	0.0001	CcSEcCtD
Prednisone—Tachycardia—Triamcinolone—psoriasis	4.87e-06	0.0001	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Hydrocortisone—psoriasis	4.83e-06	9.95e-05	CcSEcCtD
Prednisone—Hyperhidrosis—Triamcinolone—psoriasis	4.82e-06	9.94e-05	CcSEcCtD
Prednisone—Convulsion—Dexamethasone—psoriasis	4.8e-06	9.9e-05	CcSEcCtD
Prednisone—Convulsion—Betamethasone—psoriasis	4.8e-06	9.9e-05	CcSEcCtD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—psoriasis	4.79e-06	0.00402	CbGpPWpGaD
Prednisone—Feeling abnormal—Mycophenolate mofetil—psoriasis	4.79e-06	9.87e-05	CcSEcCtD
Prednisone—Insomnia—Hydrocortisone—psoriasis	4.79e-06	9.87e-05	CcSEcCtD
Prednisone—Hypertension—Betamethasone—psoriasis	4.79e-06	9.87e-05	CcSEcCtD
Prednisone—Hypertension—Dexamethasone—psoriasis	4.79e-06	9.87e-05	CcSEcCtD
Prednisone—Paraesthesia—Hydrocortisone—psoriasis	4.76e-06	9.8e-05	CcSEcCtD
Prednisone—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	4.75e-06	9.8e-05	CcSEcCtD
Prednisone—Urticaria—Cyclosporine—psoriasis	4.73e-06	9.76e-05	CcSEcCtD
Prednisone—Myalgia—Dexamethasone—psoriasis	4.72e-06	9.73e-05	CcSEcCtD
Prednisone—Myalgia—Betamethasone—psoriasis	4.72e-06	9.73e-05	CcSEcCtD
Prednisone—Body temperature increased—Cyclosporine—psoriasis	4.71e-06	9.71e-05	CcSEcCtD
Prednisone—Abdominal pain—Cyclosporine—psoriasis	4.71e-06	9.71e-05	CcSEcCtD
Prednisone—Anxiety—Dexamethasone—psoriasis	4.7e-06	9.69e-05	CcSEcCtD
Prednisone—Anxiety—Betamethasone—psoriasis	4.7e-06	9.69e-05	CcSEcCtD
Prednisone—NR3C1—AP-1 transcription factor network—JUN—psoriasis	4.7e-06	0.00394	CbGpPWpGaD
Prednisone—Vomiting—Mycophenolic acid—psoriasis	4.68e-06	9.65e-05	CcSEcCtD
Prednisone—Discomfort—Dexamethasone—psoriasis	4.66e-06	9.61e-05	CcSEcCtD
Prednisone—Discomfort—Betamethasone—psoriasis	4.66e-06	9.61e-05	CcSEcCtD
Prednisone—Dyspepsia—Hydrocortisone—psoriasis	4.66e-06	9.61e-05	CcSEcCtD
Prednisone—Haemoglobin—Methotrexate—psoriasis	4.66e-06	9.6e-05	CcSEcCtD
Prednisone—Rash—Mycophenolic acid—psoriasis	4.64e-06	9.57e-05	CcSEcCtD
Prednisone—Dermatitis—Mycophenolic acid—psoriasis	4.64e-06	9.56e-05	CcSEcCtD
Prednisone—NR3C1—Adipogenesis—LEP—psoriasis	4.64e-06	0.00389	CbGpPWpGaD
Prednisone—Haemorrhage—Methotrexate—psoriasis	4.64e-06	9.55e-05	CcSEcCtD
Prednisone—Urticaria—Mycophenolate mofetil—psoriasis	4.62e-06	9.52e-05	CcSEcCtD
Prednisone—Headache—Mycophenolic acid—psoriasis	4.62e-06	9.51e-05	CcSEcCtD
Prednisone—Decreased appetite—Hydrocortisone—psoriasis	4.6e-06	9.49e-05	CcSEcCtD
Prednisone—Abdominal pain—Mycophenolate mofetil—psoriasis	4.6e-06	9.47e-05	CcSEcCtD
Prednisone—Body temperature increased—Mycophenolate mofetil—psoriasis	4.6e-06	9.47e-05	CcSEcCtD
Prednisone—ALB—Folate Metabolism—ICAM1—psoriasis	4.59e-06	0.00385	CbGpPWpGaD
Prednisone—Fatigue—Hydrocortisone—psoriasis	4.57e-06	9.41e-05	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Triamcinolone—psoriasis	4.54e-06	9.36e-05	CcSEcCtD
Prednisone—CYP3A4—Tryptophan metabolism—CAT—psoriasis	4.54e-06	0.0038	CbGpPWpGaD
Prednisone—Anaphylactic shock—Betamethasone—psoriasis	4.53e-06	9.33e-05	CcSEcCtD
Prednisone—Anaphylactic shock—Dexamethasone—psoriasis	4.53e-06	9.33e-05	CcSEcCtD
Prednisone—Oedema—Betamethasone—psoriasis	4.53e-06	9.33e-05	CcSEcCtD
Prednisone—Oedema—Dexamethasone—psoriasis	4.53e-06	9.33e-05	CcSEcCtD
Prednisone—Insomnia—Triamcinolone—psoriasis	4.51e-06	9.3e-05	CcSEcCtD
Prednisone—ABCB1—Allograft Rejection—IL10—psoriasis	4.51e-06	0.00378	CbGpPWpGaD
Prednisone—Infection—Betamethasone—psoriasis	4.5e-06	9.27e-05	CcSEcCtD
Prednisone—Infection—Dexamethasone—psoriasis	4.5e-06	9.27e-05	CcSEcCtD
Prednisone—Paraesthesia—Triamcinolone—psoriasis	4.48e-06	9.23e-05	CcSEcCtD
Prednisone—Feeling abnormal—Prednisolone—psoriasis	4.47e-06	9.21e-05	CcSEcCtD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—psoriasis	4.46e-06	0.00373	CbGpPWpGaD
Prednisone—Shock—Betamethasone—psoriasis	4.45e-06	9.18e-05	CcSEcCtD
Prednisone—Shock—Dexamethasone—psoriasis	4.45e-06	9.18e-05	CcSEcCtD
Prednisone—Nervous system disorder—Betamethasone—psoriasis	4.44e-06	9.15e-05	CcSEcCtD
Prednisone—Nervous system disorder—Dexamethasone—psoriasis	4.44e-06	9.15e-05	CcSEcCtD
Prednisone—Tachycardia—Dexamethasone—psoriasis	4.42e-06	9.1e-05	CcSEcCtD
Prednisone—Tachycardia—Betamethasone—psoriasis	4.42e-06	9.1e-05	CcSEcCtD
Prednisone—Hypersensitivity—Cyclosporine—psoriasis	4.39e-06	9.05e-05	CcSEcCtD
Prednisone—Dyspepsia—Triamcinolone—psoriasis	4.39e-06	9.05e-05	CcSEcCtD
Prednisone—ABCB1—Allograft Rejection—IL4—psoriasis	4.39e-06	0.00368	CbGpPWpGaD
Prednisone—Nausea—Mycophenolic acid—psoriasis	4.38e-06	9.02e-05	CcSEcCtD
Prednisone—Hyperhidrosis—Betamethasone—psoriasis	4.37e-06	9.02e-05	CcSEcCtD
Prednisone—Hyperhidrosis—Dexamethasone—psoriasis	4.37e-06	9.02e-05	CcSEcCtD
Prednisone—HSD11B1—Metabolism—APOE—psoriasis	4.37e-06	0.00366	CbGpPWpGaD
Prednisone—Feeling abnormal—Hydrocortisone—psoriasis	4.36e-06	9e-05	CcSEcCtD
Prednisone—Eye disorder—Methotrexate—psoriasis	4.33e-06	8.93e-05	CcSEcCtD
Prednisone—Gastrointestinal pain—Hydrocortisone—psoriasis	4.33e-06	8.93e-05	CcSEcCtD
Prednisone—Anorexia—Betamethasone—psoriasis	4.31e-06	8.89e-05	CcSEcCtD
Prednisone—Anorexia—Dexamethasone—psoriasis	4.31e-06	8.89e-05	CcSEcCtD
Prednisone—Urticaria—Prednisolone—psoriasis	4.31e-06	8.88e-05	CcSEcCtD
Prednisone—Fatigue—Triamcinolone—psoriasis	4.3e-06	8.86e-05	CcSEcCtD
Prednisone—ALB—Vitamin B12 Metabolism—IFNG—psoriasis	4.3e-06	0.0036	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—HLA-B—psoriasis	4.29e-06	0.0036	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	4.29e-06	0.00359	CbGpPWpGaD
Prednisone—Hypersensitivity—Mycophenolate mofetil—psoriasis	4.28e-06	8.83e-05	CcSEcCtD
Prednisone—Asthenia—Cyclosporine—psoriasis	4.28e-06	8.81e-05	CcSEcCtD
Prednisone—Pruritus—Cyclosporine—psoriasis	4.22e-06	8.69e-05	CcSEcCtD
Prednisone—Urticaria—Hydrocortisone—psoriasis	4.21e-06	8.67e-05	CcSEcCtD
Prednisone—Angiopathy—Methotrexate—psoriasis	4.21e-06	8.67e-05	CcSEcCtD
Prednisone—Immune system disorder—Methotrexate—psoriasis	4.19e-06	8.63e-05	CcSEcCtD
Prednisone—Abdominal pain—Hydrocortisone—psoriasis	4.19e-06	8.63e-05	CcSEcCtD
Prednisone—Body temperature increased—Hydrocortisone—psoriasis	4.19e-06	8.63e-05	CcSEcCtD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	4.18e-06	0.00351	CbGpPWpGaD
Prednisone—Asthenia—Mycophenolate mofetil—psoriasis	4.17e-06	8.6e-05	CcSEcCtD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—JUN—psoriasis	4.14e-06	0.00347	CbGpPWpGaD
Prednisone—Musculoskeletal discomfort—Dexamethasone—psoriasis	4.12e-06	8.5e-05	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Betamethasone—psoriasis	4.12e-06	8.5e-05	CcSEcCtD
Prednisone—Pruritus—Mycophenolate mofetil—psoriasis	4.11e-06	8.48e-05	CcSEcCtD
Prednisone—Feeling abnormal—Triamcinolone—psoriasis	4.11e-06	8.47e-05	CcSEcCtD
Prednisone—Alopecia—Methotrexate—psoriasis	4.1e-06	8.44e-05	CcSEcCtD
Prednisone—Insomnia—Betamethasone—psoriasis	4.09e-06	8.44e-05	CcSEcCtD
Prednisone—Insomnia—Dexamethasone—psoriasis	4.09e-06	8.44e-05	CcSEcCtD
Prednisone—Diarrhoea—Cyclosporine—psoriasis	4.08e-06	8.4e-05	CcSEcCtD
Prednisone—Paraesthesia—Dexamethasone—psoriasis	4.06e-06	8.37e-05	CcSEcCtD
Prednisone—Paraesthesia—Betamethasone—psoriasis	4.06e-06	8.37e-05	CcSEcCtD
Prednisone—Mental disorder—Methotrexate—psoriasis	4.06e-06	8.37e-05	CcSEcCtD
Prednisone—NR3C1—Adipogenesis—PPARG—psoriasis	4.04e-06	0.00339	CbGpPWpGaD
Prednisone—Erythema—Methotrexate—psoriasis	4.04e-06	8.32e-05	CcSEcCtD
Prednisone—Malnutrition—Methotrexate—psoriasis	4.04e-06	8.32e-05	CcSEcCtD
Prednisone—SLCO1A2—Metabolism—NDUFA5—psoriasis	4.01e-06	0.00336	CbGpPWpGaD
Prednisone—Hypersensitivity—Prednisolone—psoriasis	4e-06	8.23e-05	CcSEcCtD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	3.99e-06	0.00335	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—psoriasis	3.99e-06	0.00334	CbGpPWpGaD
Prednisone—Dyspepsia—Betamethasone—psoriasis	3.98e-06	8.21e-05	CcSEcCtD
Prednisone—Dyspepsia—Dexamethasone—psoriasis	3.98e-06	8.21e-05	CcSEcCtD
Prednisone—Diarrhoea—Mycophenolate mofetil—psoriasis	3.98e-06	8.2e-05	CcSEcCtD
Prednisone—ABCB1—Allograft Rejection—HLA-A—psoriasis	3.98e-06	0.00333	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—CRP—psoriasis	3.97e-06	0.00333	CbGpPWpGaD
Prednisone—Urticaria—Triamcinolone—psoriasis	3.96e-06	8.17e-05	CcSEcCtD
Prednisone—Body temperature increased—Triamcinolone—psoriasis	3.94e-06	8.13e-05	CcSEcCtD
Prednisone—Dizziness—Cyclosporine—psoriasis	3.94e-06	8.12e-05	CcSEcCtD
Prednisone—Decreased appetite—Betamethasone—psoriasis	3.93e-06	8.11e-05	CcSEcCtD
Prednisone—Decreased appetite—Dexamethasone—psoriasis	3.93e-06	8.11e-05	CcSEcCtD
Prednisone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.91e-06	0.00328	CbGpPWpGaD
Prednisone—Hypersensitivity—Hydrocortisone—psoriasis	3.9e-06	8.04e-05	CcSEcCtD
Prednisone—Fatigue—Betamethasone—psoriasis	3.9e-06	8.04e-05	CcSEcCtD
Prednisone—Fatigue—Dexamethasone—psoriasis	3.9e-06	8.04e-05	CcSEcCtD
Prednisone—Dizziness—Mycophenolate mofetil—psoriasis	3.84e-06	7.92e-05	CcSEcCtD
Prednisone—HSD11B1—Metabolism—PPARG—psoriasis	3.81e-06	0.00319	CbGpPWpGaD
Prednisone—Vision blurred—Methotrexate—psoriasis	3.8e-06	7.84e-05	CcSEcCtD
Prednisone—Asthenia—Hydrocortisone—psoriasis	3.8e-06	7.83e-05	CcSEcCtD
Prednisone—Vomiting—Cyclosporine—psoriasis	3.79e-06	7.81e-05	CcSEcCtD
Prednisone—Rash—Cyclosporine—psoriasis	3.76e-06	7.74e-05	CcSEcCtD
Prednisone—Dermatitis—Cyclosporine—psoriasis	3.75e-06	7.74e-05	CcSEcCtD
Prednisone—Pruritus—Hydrocortisone—psoriasis	3.75e-06	7.72e-05	CcSEcCtD
Prednisone—Ill-defined disorder—Methotrexate—psoriasis	3.74e-06	7.72e-05	CcSEcCtD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.74e-06	0.00313	CbGpPWpGaD
Prednisone—Headache—Cyclosporine—psoriasis	3.73e-06	7.69e-05	CcSEcCtD
Prednisone—Anaemia—Methotrexate—psoriasis	3.73e-06	7.69e-05	CcSEcCtD
Prednisone—Feeling abnormal—Betamethasone—psoriasis	3.73e-06	7.69e-05	CcSEcCtD
Prednisone—Feeling abnormal—Dexamethasone—psoriasis	3.73e-06	7.69e-05	CcSEcCtD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—CP—psoriasis	3.73e-06	0.00312	CbGpPWpGaD
Prednisone—Gastrointestinal pain—Dexamethasone—psoriasis	3.7e-06	7.63e-05	CcSEcCtD
Prednisone—Gastrointestinal pain—Betamethasone—psoriasis	3.7e-06	7.63e-05	CcSEcCtD
Prednisone—Vomiting—Mycophenolate mofetil—psoriasis	3.7e-06	7.62e-05	CcSEcCtD
Prednisone—Hypersensitivity—Triamcinolone—psoriasis	3.67e-06	7.57e-05	CcSEcCtD
Prednisone—Rash—Mycophenolate mofetil—psoriasis	3.67e-06	7.55e-05	CcSEcCtD
Prednisone—Dermatitis—Mycophenolate mofetil—psoriasis	3.66e-06	7.55e-05	CcSEcCtD
Prednisone—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	3.65e-06	0.00306	CbGpPWpGaD
Prednisone—Headache—Mycophenolate mofetil—psoriasis	3.64e-06	7.51e-05	CcSEcCtD
Prednisone—Malaise—Methotrexate—psoriasis	3.64e-06	7.5e-05	CcSEcCtD
Prednisone—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	3.63e-06	0.00304	CbGpPWpGaD
Prednisone—Vertigo—Methotrexate—psoriasis	3.63e-06	7.47e-05	CcSEcCtD
Prednisone—Diarrhoea—Hydrocortisone—psoriasis	3.62e-06	7.47e-05	CcSEcCtD
Prednisone—Urticaria—Betamethasone—psoriasis	3.59e-06	7.41e-05	CcSEcCtD
Prednisone—Urticaria—Dexamethasone—psoriasis	3.59e-06	7.41e-05	CcSEcCtD
Prednisone—Dizziness—Prednisolone—psoriasis	3.59e-06	7.39e-05	CcSEcCtD
Prednisone—ALB—SLC-mediated transmembrane transport—CP—psoriasis	3.58e-06	0.003	CbGpPWpGaD
Prednisone—Asthenia—Triamcinolone—psoriasis	3.58e-06	7.37e-05	CcSEcCtD
Prednisone—Body temperature increased—Betamethasone—psoriasis	3.58e-06	7.37e-05	CcSEcCtD
Prednisone—Abdominal pain—Betamethasone—psoriasis	3.58e-06	7.37e-05	CcSEcCtD
Prednisone—Abdominal pain—Dexamethasone—psoriasis	3.58e-06	7.37e-05	CcSEcCtD
Prednisone—Body temperature increased—Dexamethasone—psoriasis	3.58e-06	7.37e-05	CcSEcCtD
Prednisone—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	3.57e-06	0.003	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—CARM1—psoriasis	3.55e-06	0.00298	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—CARM1—psoriasis	3.54e-06	0.00297	CbGpPWpGaD
Prednisone—Nausea—Cyclosporine—psoriasis	3.54e-06	7.3e-05	CcSEcCtD
Prednisone—Pruritus—Triamcinolone—psoriasis	3.53e-06	7.27e-05	CcSEcCtD
Prednisone—Dizziness—Hydrocortisone—psoriasis	3.5e-06	7.22e-05	CcSEcCtD
Prednisone—Convulsion—Methotrexate—psoriasis	3.5e-06	7.21e-05	CcSEcCtD
Prednisone—ALB—Folate Metabolism—IFNG—psoriasis	3.5e-06	0.00293	CbGpPWpGaD
Prednisone—Nausea—Mycophenolate mofetil—psoriasis	3.45e-06	7.12e-05	CcSEcCtD
Prednisone—Myalgia—Methotrexate—psoriasis	3.44e-06	7.08e-05	CcSEcCtD
Prednisone—Arthralgia—Methotrexate—psoriasis	3.44e-06	7.08e-05	CcSEcCtD
Prednisone—Rash—Prednisolone—psoriasis	3.42e-06	7.05e-05	CcSEcCtD
Prednisone—Dermatitis—Prednisolone—psoriasis	3.42e-06	7.04e-05	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	3.41e-06	7.03e-05	CcSEcCtD
Prednisone—SLCO1A2—Metabolism—CYP2S1—psoriasis	3.41e-06	0.00286	CbGpPWpGaD
Prednisone—Headache—Prednisolone—psoriasis	3.4e-06	7e-05	CcSEcCtD
Prednisone—Discomfort—Methotrexate—psoriasis	3.39e-06	7e-05	CcSEcCtD
Prednisone—Vomiting—Hydrocortisone—psoriasis	3.37e-06	6.94e-05	CcSEcCtD
Prednisone—Rash—Hydrocortisone—psoriasis	3.34e-06	6.88e-05	CcSEcCtD
Prednisone—Dermatitis—Hydrocortisone—psoriasis	3.34e-06	6.88e-05	CcSEcCtD
Prednisone—Headache—Hydrocortisone—psoriasis	3.32e-06	6.84e-05	CcSEcCtD
Prednisone—Dizziness—Triamcinolone—psoriasis	3.3e-06	6.8e-05	CcSEcCtD
Prednisone—Anaphylactic shock—Methotrexate—psoriasis	3.29e-06	6.79e-05	CcSEcCtD
Prednisone—Infection—Methotrexate—psoriasis	3.27e-06	6.74e-05	CcSEcCtD
Prednisone—Asthenia—Betamethasone—psoriasis	3.25e-06	6.69e-05	CcSEcCtD
Prednisone—Asthenia—Dexamethasone—psoriasis	3.25e-06	6.69e-05	CcSEcCtD
Prednisone—Nervous system disorder—Methotrexate—psoriasis	3.23e-06	6.66e-05	CcSEcCtD
Prednisone—Nausea—Prednisolone—psoriasis	3.22e-06	6.64e-05	CcSEcCtD
Prednisone—Pruritus—Betamethasone—psoriasis	3.2e-06	6.6e-05	CcSEcCtD
Prednisone—Pruritus—Dexamethasone—psoriasis	3.2e-06	6.6e-05	CcSEcCtD
Prednisone—Skin disorder—Methotrexate—psoriasis	3.2e-06	6.59e-05	CcSEcCtD
Prednisone—Hyperhidrosis—Methotrexate—psoriasis	3.18e-06	6.56e-05	CcSEcCtD
Prednisone—Vomiting—Triamcinolone—psoriasis	3.17e-06	6.54e-05	CcSEcCtD
Prednisone—Nausea—Hydrocortisone—psoriasis	3.15e-06	6.48e-05	CcSEcCtD
Prednisone—Rash—Triamcinolone—psoriasis	3.14e-06	6.48e-05	CcSEcCtD
Prednisone—Dermatitis—Triamcinolone—psoriasis	3.14e-06	6.47e-05	CcSEcCtD
Prednisone—Anorexia—Methotrexate—psoriasis	3.14e-06	6.47e-05	CcSEcCtD
Prednisone—Headache—Triamcinolone—psoriasis	3.12e-06	6.44e-05	CcSEcCtD
Prednisone—NR3C1—AP-1 transcription factor network—TP53—psoriasis	3.1e-06	0.0026	CbGpPWpGaD
Prednisone—Diarrhoea—Betamethasone—psoriasis	3.1e-06	6.38e-05	CcSEcCtD
Prednisone—Diarrhoea—Dexamethasone—psoriasis	3.1e-06	6.38e-05	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Methotrexate—psoriasis	3e-06	6.18e-05	CcSEcCtD
Prednisone—Dizziness—Dexamethasone—psoriasis	2.99e-06	6.17e-05	CcSEcCtD
Prednisone—Dizziness—Betamethasone—psoriasis	2.99e-06	6.17e-05	CcSEcCtD
Prednisone—Insomnia—Methotrexate—psoriasis	2.98e-06	6.14e-05	CcSEcCtD
Prednisone—Nausea—Triamcinolone—psoriasis	2.96e-06	6.11e-05	CcSEcCtD
Prednisone—Paraesthesia—Methotrexate—psoriasis	2.96e-06	6.09e-05	CcSEcCtD
Prednisone—ALB—Folate Metabolism—NFKB1—psoriasis	2.91e-06	0.00244	CbGpPWpGaD
Prednisone—Dyspepsia—Methotrexate—psoriasis	2.9e-06	5.97e-05	CcSEcCtD
Prednisone—Vomiting—Betamethasone—psoriasis	2.88e-06	5.93e-05	CcSEcCtD
Prednisone—Vomiting—Dexamethasone—psoriasis	2.88e-06	5.93e-05	CcSEcCtD
Prednisone—Decreased appetite—Methotrexate—psoriasis	2.86e-06	5.9e-05	CcSEcCtD
Prednisone—Rash—Dexamethasone—psoriasis	2.85e-06	5.88e-05	CcSEcCtD
Prednisone—Rash—Betamethasone—psoriasis	2.85e-06	5.88e-05	CcSEcCtD
Prednisone—Dermatitis—Betamethasone—psoriasis	2.85e-06	5.87e-05	CcSEcCtD
Prednisone—Dermatitis—Dexamethasone—psoriasis	2.85e-06	5.87e-05	CcSEcCtD
Prednisone—NR3C1—AP-1 transcription factor network—IL6—psoriasis	2.84e-06	0.00238	CbGpPWpGaD
Prednisone—Fatigue—Methotrexate—psoriasis	2.84e-06	5.85e-05	CcSEcCtD
Prednisone—Headache—Dexamethasone—psoriasis	2.83e-06	5.84e-05	CcSEcCtD
Prednisone—Headache—Betamethasone—psoriasis	2.83e-06	5.84e-05	CcSEcCtD
Prednisone—ALB—Vitamin B12 Metabolism—TNF—psoriasis	2.78e-06	0.00233	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—IFNG—psoriasis	2.78e-06	0.00233	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—psoriasis	2.73e-06	0.00229	CbGpPWpGaD
Prednisone—Feeling abnormal—Methotrexate—psoriasis	2.71e-06	5.59e-05	CcSEcCtD
Prednisone—Gastrointestinal pain—Methotrexate—psoriasis	2.69e-06	5.55e-05	CcSEcCtD
Prednisone—Nausea—Betamethasone—psoriasis	2.69e-06	5.54e-05	CcSEcCtD
Prednisone—Nausea—Dexamethasone—psoriasis	2.69e-06	5.54e-05	CcSEcCtD
Prednisone—NR3C1—SIDS Susceptibility Pathways—CXCL8—psoriasis	2.66e-06	0.00223	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—IFNG—psoriasis	2.65e-06	0.00222	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	2.65e-06	0.00222	CbGpPWpGaD
Prednisone—Urticaria—Methotrexate—psoriasis	2.62e-06	5.39e-05	CcSEcCtD
Prednisone—Body temperature increased—Methotrexate—psoriasis	2.6e-06	5.37e-05	CcSEcCtD
Prednisone—Abdominal pain—Methotrexate—psoriasis	2.6e-06	5.37e-05	CcSEcCtD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—IL6—psoriasis	2.5e-06	0.0021	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—STAT3—psoriasis	2.48e-06	0.00208	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—JUN—psoriasis	2.48e-06	0.00208	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—CXCL8—psoriasis	2.47e-06	0.00207	CbGpPWpGaD
Prednisone—Hypersensitivity—Methotrexate—psoriasis	2.43e-06	5e-05	CcSEcCtD
Prednisone—NR3C1—SIDS Susceptibility Pathways—NFKB1—psoriasis	2.38e-06	0.002	CbGpPWpGaD
Prednisone—Asthenia—Methotrexate—psoriasis	2.36e-06	4.87e-05	CcSEcCtD
Prednisone—Pruritus—Methotrexate—psoriasis	2.33e-06	4.8e-05	CcSEcCtD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	2.31e-06	0.00194	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	2.31e-06	0.00194	CbGpPWpGaD
Prednisone—ALB—Platelet degranulation—VEGFA—psoriasis	2.26e-06	0.0019	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—TNF—psoriasis	2.26e-06	0.0019	CbGpPWpGaD
Prednisone—Diarrhoea—Methotrexate—psoriasis	2.25e-06	4.64e-05	CcSEcCtD
Prednisone—ALB—Vitamin B12 Metabolism—IL6—psoriasis	2.24e-06	0.00188	CbGpPWpGaD
Prednisone—Dizziness—Methotrexate—psoriasis	2.18e-06	4.49e-05	CcSEcCtD
Prednisone—ALB—Hemostasis—ITGAL—psoriasis	2.18e-06	0.00182	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—psoriasis	2.16e-06	0.00181	CbGpPWpGaD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	2.16e-06	0.00181	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—TNF—psoriasis	2.15e-06	0.0018	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—VDR—psoriasis	2.12e-06	0.00177	CbGpPWpGaD
Prednisone—Vomiting—Methotrexate—psoriasis	2.09e-06	4.32e-05	CcSEcCtD
Prednisone—Rash—Methotrexate—psoriasis	2.08e-06	4.28e-05	CcSEcCtD
Prednisone—Dermatitis—Methotrexate—psoriasis	2.07e-06	4.28e-05	CcSEcCtD
Prednisone—Headache—Methotrexate—psoriasis	2.06e-06	4.25e-05	CcSEcCtD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.03e-06	0.0017	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—VEGFA—psoriasis	2e-06	0.00168	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—TP53—psoriasis	1.99e-06	0.00167	CbGpPWpGaD
Prednisone—ALB—Metabolism—NDUFA5—psoriasis	1.96e-06	0.00164	CbGpPWpGaD
Prednisone—Nausea—Methotrexate—psoriasis	1.96e-06	4.03e-05	CcSEcCtD
Prednisone—NR3C1—SIDS Susceptibility Pathways—TNF—psoriasis	1.85e-06	0.00155	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.83e-06	0.00153	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—IL6—psoriasis	1.83e-06	0.00153	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—CP—psoriasis	1.82e-06	0.00153	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—TNF—psoriasis	1.8e-06	0.00151	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.79e-06	0.0015	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—NDUFA5—psoriasis	1.76e-06	0.00147	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	1.74e-06	0.00146	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—IL6—psoriasis	1.73e-06	0.00145	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—TNF—psoriasis	1.72e-06	0.00144	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—NDUFA5—psoriasis	1.72e-06	0.00144	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.71e-06	0.00143	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—CARM1—psoriasis	1.71e-06	0.00143	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP2S1—psoriasis	1.67e-06	0.0014	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CARM1—psoriasis	1.66e-06	0.0014	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.64e-06	0.00137	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	1.59e-06	0.00134	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.56e-06	0.0013	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	1.52e-06	0.00128	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—IL6—psoriasis	1.5e-06	0.00125	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP2S1—psoriasis	1.5e-06	0.00125	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—PPARG—psoriasis	1.48e-06	0.00124	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP2S1—psoriasis	1.46e-06	0.00122	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—IL6—psoriasis	1.45e-06	0.00122	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.13e-06	0.000948	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.09e-06	0.000913	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—NDUFA5—psoriasis	1.06e-06	0.000886	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CAT—psoriasis	1.02e-06	0.000858	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—VDR—psoriasis	1.02e-06	0.000854	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1e-06	0.000841	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	9.88e-07	0.000829	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP2S1—psoriasis	8.99e-07	0.000754	CbGpPWpGaD
Prednisone—ALB—Hemostasis—NOS2—psoriasis	8.93e-07	0.000749	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	8.73e-07	0.000732	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	8.47e-07	0.00071	CbGpPWpGaD
Prednisone—ALB—Metabolism—CARM1—psoriasis	8.13e-07	0.000682	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—APOE—psoriasis	7.96e-07	0.000667	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.84e-07	0.000657	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.6e-07	0.000637	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	7.47e-07	0.000626	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CARM1—psoriasis	7.3e-07	0.000612	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CARM1—psoriasis	7.13e-07	0.000597	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—PPARG—psoriasis	7.1e-07	0.000595	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PPARG—psoriasis	6.93e-07	0.000581	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.82e-07	0.000572	CbGpPWpGaD
Prednisone—ALB—Hemostasis—VEGFA—psoriasis	5.17e-07	0.000434	CbGpPWpGaD
Prednisone—ALB—Metabolism—CAT—psoriasis	5e-07	0.000419	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CAT—psoriasis	4.49e-07	0.000376	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CARM1—psoriasis	4.39e-07	0.000368	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CAT—psoriasis	4.38e-07	0.000367	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TP53—psoriasis	3.91e-07	0.000328	CbGpPWpGaD
Prednisone—ALB—Metabolism—APOE—psoriasis	3.89e-07	0.000326	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—APOE—psoriasis	3.49e-07	0.000292	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—APOE—psoriasis	3.41e-07	0.000285	CbGpPWpGaD
Prednisone—ALB—Metabolism—PPARG—psoriasis	3.39e-07	0.000284	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PPARG—psoriasis	3.04e-07	0.000255	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PPARG—psoriasis	2.97e-07	0.000249	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CAT—psoriasis	2.7e-07	0.000226	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—APOE—psoriasis	2.1e-07	0.000176	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PPARG—psoriasis	1.83e-07	0.000153	CbGpPWpGaD
